Secondary Ph+ acute lymphoblastic leukemia after temozolomide

Ann Hematol. 2005 Oct;84(11):760-2. doi: 10.1007/s00277-005-1093-6. Epub 2005 Jul 26.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents, Alkylating / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Benzamides
  • Central Nervous System Neoplasms / drug therapy*
  • Dacarbazine / adverse effects
  • Dacarbazine / analogs & derivatives*
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / chemically induced*
  • Male
  • Piperazines / administration & dosage
  • Pyrimidines / administration & dosage
  • Temozolomide

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Alkylating
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Dacarbazine
  • Imatinib Mesylate
  • Temozolomide